Latest News on ILMN

Financial News Based On Company


Advertisement
Advertisement

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

https://www.zacks.com/stock/news/2793095/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

BSX's Neuromodulation Prospect Looks Strong: What's Behind It?

https://www.zacks.com/stock/news/2792839/bsxs-neuromodulation-prospect-looks-strong-whats-behind-it
Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.

Top 3 Genomics Stocks to Consider for Your Portfolio

https://www.zacks.com/stock/news/2792339/top-3-genomics-stocks-to-consider-for-your-portfolio
Genomics gains momentum as EDIT, SANA, and PACB emerge as standout picks amid rapid advances in sequencing and gene editing.

ALKS or ILMN: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2789445/alks-or-ilmn-which-is-the-better-value-stock-right-now
ALKS vs. ILMN: Which Stock Is the Better Value Option?

Cisco, Morgan Stanley And FTAI Aviation On CNBC's 'Final Trades' - Cisco Systems ( NASDAQ:CSCO ) , FTAI Aviation ( NASDAQ:FTAI )

https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/11/48776986/cisco-morgan-stanley-ftai-aviation-and-a-health-care-stock-on-cnbcs-final-tra
On CNBC's "Halftime Report Final Trades," Jim Lebenthal, partner at Cerity Partners, named Cisco Systems, Inc. ( NASDAQ:CSCO ) ahead of quarterly earnings, saying sentiment is clearly positive and the fundamentals justify it.
Advertisement

Qiagen ( QGEN ) Q3 2025 Earnings Call Transcript

https://www.fool.com/earnings/call-transcripts/2025/11/05/qiagen-qgen-q3-2025-earnings-call-transcript/
Image source: The Motley Fool.Wednesday, November 5, 2025 at 9:30 a.m. ETChief Executive Officer - Thierry BernardContinue reading ...

Biotech ETFs In Focus as Illumina Soars 23% - Is the Genomics Winter Over? - ARK Genomic Revolution ETF ( BATS:ARKG ) , iShares Biotechnology ETF ( NASDAQ:IBB )

https://www.benzinga.com/etfs/sector-etfs/25/11/48593510/biotech-etf-illumina-stock-genomics
Biotech investors finally got a dose of good news this week. Illumina Inc ( NASDAQ:ILMN ) staged a powerful comeback, with the stock surging over 23% on Friday after topping its third-quarter guidance while narrowing its full-year revenue decline forecast.

Global Microfluidics Market to Surpass USD 32.67 Billion by 2029 | MarketsandMarkets™

https://www.benzinga.com/pressreleases/25/11/g48590273/global-microfluidics-market-to-surpass-usd-32-67-billion-by-2029-marketsandmarkets
Delray Beach, FL, Nov. 03, 2025 ( GLOBE NEWSWIRE ) -- The global microfluidics market, valued at US$21.36 billion in 2023, stood at US$22.43 billion in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$32.67 billion by the ...

Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results - Amazon.com ( NASDAQ:AMZN ) , Butterfly Network ( NYSE:BFLY )

https://www.benzinga.com/news/25/10/48568925/dow-falls-over-100-points-amazon-posts-upbeat-q3-results
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 100 points on Friday. The Dow traded down 0.30% to 47,379.27 while the NASDAQ rose 0.27% to 23,644.68. The S&P 500 also fell, dropping, 0.07% to 6,817.76. Consumer discretionary shares jumped by 3.8% on ...

Illumina Options Trading: A Deep Dive into Market Sentiment - Illumina ( NASDAQ:ILMN )

https://www.benzinga.com/insights/options/25/10/48567755/illumina-options-trading-a-deep-dive-into-market-sentiment
Deep-pocketed investors have adopted a bullish approach towards Illumina ( NASDAQ:ILMN ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
Advertisement

Why Is Illumina Stock Soaring Today - Illumina ( NASDAQ:ILMN )

https://www.benzinga.com/markets/earnings/25/10/48565485/dna-sequencing-firm-illumina-sees-strong-clinical-market-momentum-stock-soars
Illumina Inc. ( NASDAQ:ILMN ) stock is trading higher after the company reported better-than-expected third-quarter earnings. The DNA sequencing company reported adjusted earnings of $1.34 per share, beating the consensus of $1.17.

Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday - Astera Labs ( NASDAQ:ALAB ) , Arcosa ( NYSE:ACA )

https://www.benzinga.com/trading-ideas/movers/25/10/48564489/cloudflare-posts-upbeat-q3-results-joins-amazon-roku-coinbase-atlassian-and-other-big-stocks
U.S. stocks were higher, with the Nasdaq Composite gaining around 1% on Friday. Shares of Cloudflare, Inc. ( NYSE:NET ) rose sharply during Friday's session after the company reported better-than-expected third-quarter financial results and issued fourth-quarter guidance above estimates.

Illumina ( ILMN ) Beats Q3 Earnings and Revenue Estimates

https://www.zacks.com/stock/news/2782032/illumina-ilmn-beats-q3-earnings-and-revenue-estimates
Illumina (ILMN) delivered earnings and revenue surprises of +15.52% and +1.73%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Solid Long-term Prospects in Semis: Buy NVIDIA and Hold STMicroelectronics

https://www.zacks.com/commentary/2778544/solid-long-term-prospects-in-semis-buy-nvidia-and-hold-stmicroelectronics
Semiconductor stocks power the AI era, tested by trade tensions and rich valuations. NVIDIA leads, while STMicroelectronics eyes recovery.

Axsome Therapeutics ( AXSM ) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

https://www.zacks.com/stock/news/2777891/axsome-therapeutics-axsm-may-report-negative-earnings-know-the-trend-ahead-of-next-weeks-release
Axsome (AXSM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Advertisement

Illumina ( ILMN ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

https://www.zacks.com/stock/news/2775392/illumina-ilmn-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release
Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Looking Into Illumina Inc's Recent Short Interest - Illumina ( NASDAQ:ILMN )

https://www.benzinga.com/insights/short-sellers/25/10/48351350/looking-into-illumina-incs-recent-short-interest
Illumina Inc's ( NYSE:ILMN ) short interest as a percent of float has fallen 10.0% since its last report. According to exchange reported data, there are now 6.61 million shares sold short, which is 6.39% of all regular shares that are available for trading.

Keros Therapeutics ( KROS ) Moves 9.8% Higher: Will This Strength Last?

https://www.zacks.com/stock/news/2773090/keros-therapeutics-kros-moves-98-higher-will-this-strength-last
Keros Therapeutics (KROS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

JPMorgan, Alibaba, Columbia Banking System And A Health Care Stock On CNBC's 'Final Trades' - Alibaba Gr Hldgs ( NYSE:BABA ) , Columbia Banking System ( NASDAQ:COLB )

https://www.benzinga.com/trading-ideas/long-ideas/25/10/48324614/jpmorgan-alibaba-columbia-banking-system-and-a-health-care-stock-on-cnbcs-final-trades
On CNBC's "Halftime Report Final Trades," on Monday, Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said JPMorgan Chase & Co. ( NYSE:JPM ) is still his favorite financial as a long-term investor. The stock looks great, he added.

PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations

https://www.zacks.com/stock/news/2772369/pacbio-aims-to-expand-multiomic-capabilities-via-latest-innovations
PACB unveils new SPRQ-Nx chemistry to cut sequencing costs and boost multiomic features on Revio and Vega.
Advertisement

Will Robust Cardiovascular Performance Fuel BSX's Q3 Earnings?

https://www.zacks.com/stock/news/2769946/will-robust-cardiovascular-performance-fuel-bsxs-q3-earnings
Boston Scientific's strong cardiovascular and MedSurg momentum, powered by innovations like WATCHMAN FLX Pro and AGENT DCB, could drive solid Q3 results.

KMDA or ILMN: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2769433/kmda-or-ilmn-which-is-the-better-value-stock-right-now
KMDA vs. ILMN: Which Stock Is the Better Value Option?

Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns - Apple ( NASDAQ:AAPL ) , Amazon.com ( NASDAQ:AMZN )

https://www.benzinga.com/markets/tech/25/10/48219448/cathie-wood-warns-wall-street-is-missing-ais-biggest-opportunity-in-healthcare-calling-it-sleeper-in
Ark Invest CEO Cathie Wood told investors the real AI revolution isn't in chatbots or self-driving cars, it's happening in hospitals and labs and Wall Street is largely overlooking it. Speaking at the All-In Summit 2025 in September, Wood highlighted healthcare as "the most profound application ...

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

https://www.zacks.com/stock/news/2766061/how-to-find-strong-medical-stocks-slated-for-positive-earnings-surprises
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Why Illumina ( ILMN ) is a Top Momentum Stock for the Long-Term

https://www.zacks.com/stock/news/2765422/why-illumina-ilmn-is-a-top-momentum-stock-for-the-long-term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Advertisement

Will Illumina ( ILMN ) Beat Estimates Again in Its Next Earnings Report?

https://www.zacks.com/stock/news/2763850/will-illumina-ilmn-beat-estimates-again-in-its-next-earnings-report
Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

https://www.zacks.com/stock/news/2762511/these-2-medical-stocks-could-beat-earnings-why-they-should-be-on-your-radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

ILMN Stock Set to Benefit From the Launch of New BioInsight Division

https://www.zacks.com/stock/news/2761336/ilmn-stock-set-to-benefit-from-the-launch-of-new-bioinsight-division
Illumina launches BioInsight to harness multiomic data, accelerate drug discovery, and boost disease diagnosis.

Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker

https://www.zacks.com/stock/news/2760717/illumina-to-join-pharma-partners-for-cdx-development-on-kras-biomarker
ILMN partners with pharma leaders to advance KRAS-focused companion diagnostics through its TruSight Oncology platform.

PacBio Enters Carrier Screening Market With PureTarget Expansion

https://www.zacks.com/stock/news/2759686/pacbio-enters-carrier-screening-market-with-puretarget-expansion
PACB expands its PureTarget portfolio, streamlining carrier screening with HiFi sequencing to meet rising global demand.
Advertisement

KMDA vs. ILMN: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2759099/kmda-vs-ilmn-which-stock-is-the-better-value-option
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Kamada ( KMDA Quick QuoteKMDA - ) and Illumina ( ILMN Quick QuoteILMN - ) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer ...

TEM vs. ILMN: Which Precision Oncology Stock Is Worth Buying Now?

https://www.zacks.com/stock/news/2757569/tem-vs-ilmn-which-precision-oncology-stock-is-worth-buying-now
As precision oncology advances, Tempus and Illumina lead the way with innovation. Which stock shows stronger growth momentum now?

Here's Why Illumina ( ILMN ) is a Strong Momentum Stock

https://www.zacks.com/stock/news/2755693/heres-why-illumina-ilmn-is-a-strong-momentum-stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD

https://www.zacks.com/stock/news/2755491/tempus-ai-enhances-cancer-research-tools-with-fda-cleared-xr-ivd
TEM secures FDA clearance for its xR IVD device, advancing RNA-based cancer research and precision medicine tools.

3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025

https://www.zacks.com/stock/news/2753542/3-promising-genomics-synthetic-biology-stocks-in-spotlight-in-2025
GeneDx, Twist Bioscience and Wave Life Sciences are emerging as key players in the fast-growing genomics and synthetic biology space.
Advertisement

China's MGI Tech touts 10-minute genome reading with new sequencer

https://www.scmp.com/tech/big-tech/article/3324917/chinas-mgi-tech-touts-worlds-fastest-gene-sequencer-10-minutes-read-genome
Shenzhen-based MGI Tech unveiled what it claims to be the world's fastest gene sequencer, an advance that promises to help accelerate breakthroughs in cancer genomics and rare disease research. The company said at a launch event on Tuesday that the DNBSEQ-T7+ can sequence 144 human genomes a day, ...

ILMN Stock to Gain From the Launch of Illumina Protein Prep Assay

https://www.zacks.com/stock/news/2748511/ilmn-stock-to-gain-from-the-launch-of-illumina-protein-prep-assay
The Illumina Protein Prep rollout boosts multiomics, strengthens disease insights and supports ILMN stock momentum.

CRISPR Therapeutics ( CRSP ) Down 5.3% Since Last Earnings Report: Can It Rebound?

https://www.zacks.com/stock/news/2746830/crispr-therapeutics-crsp-down-53-since-last-earnings-report-can-it-rebound
CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Scan, Play, Discover: Orca Scan Launches QR-Powered Retro Game

https://www.benzinga.com/pressreleases/25/09/n47444797/scan-play-discover-orca-scan-launches-qr-powered-retro-game
CAMBRIDGE, England, Sept. 2, 2025 /PRNewswire/ -- 'OrcaCam' showcases Cambridge's history of innovation and demonstrates how a simple QR code can instantly launch a cross-platform game on any device - with no download required.

Why Illumina ( ILMN ) is a Top Momentum Stock for the Long-Term

https://www.zacks.com/stock/news/2745478/why-illumina-ilmn-is-a-top-momentum-stock-for-the-long-term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Advertisement

Should Boston Scientific Stock Be in Your Portfolio Right Now?

https://www.zacks.com/stock/news/2741539/should-boston-scientific-stock-be-in-your-portfolio-right-now
BSX's global expansion and MedSurg growth boost Q2 momentum, though currency and macro headwinds weigh on the same.

Icahn Hedge Fund's Q2 Moves: Centuri Stake Soars, JetBlue Held, 2 Positions Exited - SandRidge Energy ( NYSE:SD ) , JetBlue Airways ( NASDAQ:JBLU ) , Centuri Holdings ( NYSE:CTRI ) , Intl Flavors & Fragrances ( NYSE:IFF )

https://www.benzinga.com/markets/hedge-funds/25/08/47166066/icahn-hedge-funds-q2-moves-centuri-stake-soars-jetblue-held-2-positions-exited
Icahn boosts Centuri stake 158%, keeps JetBlue and utilities steady. Portfolio shifts favor infrastructure, utilities, and cash flow over cyclical or speculative bets. Get more market-moving news first with AI-powered analysis that turns noise into opportunity.

NICE Stock Stops Being Nice, Has A Bearish Breakdown - Illumina ( NASDAQ:ILMN ) , NICE ( NASDAQ:NICE )

https://www.benzinga.com/markets/equities/25/08/47156699/nice-stock-stops-being-nice-has-a-bearish-breakdown
NICE Ltd. NICE has entered Phase 9 of its 18-phase Adhishthana cycle on the monthly chart, and the technical picture has deteriorated. The stock appears to have broken its Adhishthana Cakra to the downside, a signal that often precedes a long stretch of consolidation and weakness.

TMO Receives FDA Approval for Oncomine Dx Target Test

https://www.zacks.com/stock/news/2716721/tmo-receives-fda-approval-for-oncomine-dx-target-test
Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS treatment.

Cathie Wood's Thursday Bet: ARK Just Bought $31 Million Worth Of Falling Deere Stock, Also Loads Up On Block, Robinhood Shares - ARK Innovation ETF ( BATS:ARKK )

https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/08/47145329/cathie-woods-thursday-bet-ark-just-bought-31-million-worth-of-falling-deere-stock-also
Ark Invest, led by Cathie Wood, made significant trades on Thursday - focusing on Deere & Co. DE, Block Inc. XYZ and Robinhood Markets Inc. HOOD. ArrivedBuy shares of homes and vacation rentals for as little as $100. Get Started WiserAdvisorGet matched with a trusted, local financial advisor for ...
Advertisement

BioStem Technologies Appoints Brandon Poe as Chief Financial Officer - BioStem Technologies ( OTC:BSEM ) , Illumina ( NASDAQ:ILMN )

https://www.benzinga.com/pressreleases/25/08/g47137516/biostem-technologies-appoints-brandon-poe-as-chief-financial-officer
POMPANO BEACH, Fla., Aug. 14, 2025 ( GLOBE NEWSWIRE ) -- BioStem Technologies, Inc. ( "BioStem" or the "Company" ) BSEM, a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the ...

KMDA vs. ILMN: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2712651/kmda-vs-ilmn-which-stock-is-the-better-value-option
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada ( KMDA Quick QuoteKMDA - ) and Illumina ( ILMN Quick QuoteILMN - ) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

https://www.zacks.com/stock/news/2707288/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Illumina Settles With DOJ, Veterans To End Whistleblower Lawsuit - Illumina ( NASDAQ:ILMN )

https://www.benzinga.com/news/legal/25/08/46918066/illumina-settles-with-doj-veterans-to-end-whistleblower-lawsuit
Illumina will pay $9.8 million, including $4.3 million in restitution, to settle false claims related to software vulnerabilities. Whistleblower will receive $1.9 million from the settlement under the False Claims Act. Get special access to three exclusive "Top 10 Stocks" power lists today, ...

Illumina ( ILMN ) Reliance on International Sales: What Investors Need to Know

https://www.zacks.com/stock/news/2667423/illumina-ilmn-reliance-on-international-sales-what-investors-need-to-know
Evaluate Illumina's (ILMN) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement